Mail

TEVA - Teva Pharmaceutical Industries Limited

NYSE - NYSE Delayed Price. Currency in USD

7.83

-0.28 (-3.45%)

At close: 4:01PM EDT

Stock chart is not supported by your current browser

Previous Close	8.11
Open	0.00
Bid	7.83 x 43500
Ask	7.89 x 28000
Day's Range	0.00 - 0.00
52 Week Range
Volume	0
Avg. Volume	18,510,579

Market Cap	8.414B
Beta (3Y Monthly)	2.46
PE Ratio (TTM)	N/A
EPS (TTM)	-3.42
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	2017-11-27
1y Target Est	13.95

Trade prices are not sourced from all markets

All

News

Press Releases

Zacks11 hours ago
3 Key Takeaways From J&J's (JNJ) Q2 Earnings Announcement
Here are some of the highlights of J&J's (JNJ) second-quarter earnings call.
ACCESSWIRE16 hours ago
SHAREHOLDER ALERT: HL TEVA FRED: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / July 18, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss ...
GlobeNewswire18 hours ago
Barbuto & Johansson, P.A. reminds TEVA, EQT, FRED and RBGLY Shareholders of Class Action Deadlines
WELLINGTON, Fla., July 18, 2019 -- Barbuto & Johansson, P.A. (“BARJO”) and Of Counsel, Neil Rothstein, Esq. (with over 30 years of Securities Class Action Experience,.
GlobeNewswire20 hours ago
SHAREHOLDER ALERT: PYX BUD TEVA RBGLY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, July 18, 2019 -- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a.
GlobeNewswireyesterday
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BUD, EROS, PSMT, TEVA INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
NEW ORLEANS, July 17, 2019 -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending.
Zacks2 days ago
Teva Pharmaceutical Industries Ltd. (TEVA) Dips More Than Broader Markets: What You Should Know
Teva Pharmaceutical Industries Ltd. (TEVA) closed at $8.11 in the latest trading session, marking a -1.1% move from the prior day.
ACCESSWIRE2 days ago
CLASS ACTION UPDATE for TEVA, FDX and RBGLY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / July 17, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders ...
ACCESSWIRE2 days ago
Class Action Update - ASNA, BUD & TEVA - Bronstein, Gewirtz & Grossman, LLC
NEW YORK, NY / ACCESSWIRE / July 17, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed againstthe following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. If you suffered a loss, you can request that the Court appoint you as lead plaintiff.
Motley Fool2 days ago
3 Drug Stocks With Unimaginably Low P/E Ratios
These drug developers are all valued at less than four times this year's projected earnings per share.
ACCESSWIRE2 days ago
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CLDR, TEVA and FRED
CEDARHURST, NY / ACCESSWIRE / July 16, 2019 / The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses. If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court.
GlobeNewswire2 days ago
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Pivotal Software, Eros International, Teva Pharmaceutical Industries, and Helius Medical Technologies and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Pivotal Software, Inc., Eros International Plc, Teva Pharmaceutical Industries Ltd, and Helius Medical Technologies, Inc. Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Class Period: Securities pursuant or traceable to Pivotal’s April 2018 initial public offering (“IPO”) and/or securities purchased or acquired between April 24, 2019 and June 4, 2019 (the “Class Period”).
Zacks3 days ago
Teva Shares Fall Further as Morgan Stanley Downgrades Rating
Shares of Teva (TEVA) are on a downtrend on the risk of high litigation costs related to opioid epidemic in the United States. Morgan Stanley downgrades its rating on Teva.
ACCESSWIRE3 days ago
CLASS ACTION UPDATE for EROS, TEVA and FRED: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / July 16, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders ...
Zacks3 days ago
J&J (JNJ) Beats on Q2 Earnings, Ups 2019 Sales Growth View
J&J (JNJ) beats estimates for both earnings and sales in the second quarter of 2019 and raises 2019 guidance for operational sales growth for the second time this year.
GlobeNewswire3 days ago
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Teva Pharmaceutical Industries Ltd. (“Teva” or “the Company”) (NYSE: TEVA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.
GlobeNewswire3 days ago
CLASS ACTION UPDATE for BUD, TEVA, EQT and INS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, July 16, 2019 -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies..
GlobeNewswire3 days ago
SHAREHOLDER ALERT: CLAIMSFILER REMINDS BUD, EROS, TEVA INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
NEW ORLEANS, July 15, 2019 -- ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits:.
Motley Fool4 days ago
Why Callon Petroleum, Teva Pharmaceutical Industries, and PG&E Slumped Today
The indexes didn't make major moves today, but these stocks did.
ACCESSWIRE4 days ago
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ASNA, BUD and TEVA
NEW YORK, NY / ACCESSWIRE / July 15, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
ACCESSWIRE4 days ago
Class Action Reminder - ASNA, BUD & TEVA - Bronstein, Gewirtz & Grossman, LLC
NEW YORK, NY / ACCESSWIRE / July 15, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed againstthe following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. If you suffered a loss, you can request that the Court appoint you as lead plaintiff.
Business Wire4 days ago
Teva Announces FDA Approval of AirDuo® Digihaler™ (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved AirDuo® Digihaler™ (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder, a combination therapy digital inhaler with built-in sensors that connects to a companion mobile application to provide information on inhaler use to people with asthma. AirDuo® Digihaler™ is indicated for the treatment of asthma in patients aged 12 years and older.
ACCESSWIRE5 days ago
SHAREHOLDER ALERT: PSMT TEVA FDX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / July 14, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have ...
ACCESSWIRE7 days ago
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PYX, TEVA and FDX
NEW YORK, NY / ACCESSWIRE / July 12, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have ...
GlobeNewswire7 days ago
ASNA, BUD & TEVA - Bronstein, Gewirtz & Grossman, LLC Class Action Announcement
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.